pharmaceutical failure
Sanofi’s $1 Billion Bet on Muscular Dystrophy Drug Falters, Fulcrum Shares Plummet
Sanofi, Fulcrum, muscular dystrophy drug, pharmaceutical failure, stock market impact
Actionable Insights Powered by AI
Sanofi, Fulcrum, muscular dystrophy drug, pharmaceutical failure, stock market impact